ViiV’s New HIV Drug “Trii” Has Officially Been FDA-Approved
Triumeq is a tablet that must be taken daily. Each tablet contains 50 mg dolutegravir, 600 mg abacavir, and 300 mg lamivudine. The correct dose is one pill taken once daily, either with or without food.
FDA approval is based on data from two clinical trials: In one trial involving people starting ARV therapy for the first time, the regimen was found to be superior to Atripla. Another study confirmed that taking Triumeq results in blood levels of the ARVs equivalent to all 3 drugs taken together as separate tablets.
It is not recommended for people with known HIV resistance to abacavir, lamivudine, or any of the approved intergrase inhibitors.
Click here for a complete guide to the latest fixed-dose, once-daily combination tablet, Triumeq.

ViiV’s New HIV Drug “Trii” Has Officially Been FDA-Approved

  • Triumeq is a tablet that must be taken daily. Each tablet contains 50 mg dolutegravir, 600 mg abacavir, and 300 mg lamivudine. The correct dose is one pill taken once daily, either with or without food.
  • FDA approval is based on data from two clinical trials: In one trial involving people starting ARV therapy for the first time, the regimen was found to be superior to Atripla. Another study confirmed that taking Triumeq results in blood levels of the ARVs equivalent to all 3 drugs taken together as separate tablets.
  • It is not recommended for people with known HIV resistance to abacavir, lamivudine, or any of the approved intergrase inhibitors.


Click here for a complete guide to the latest fixed-dose, once-daily combination tablet, Triumeq.

POZ Opinion: Reevaluate the FDA Gay Blood Ban
A gay California mayor wants to stop discrimination against gay men who want to donate blood:
"The ban was imposed in 1983 when there were no reliable tests for screening blood for HIV/AIDS. It was also made during a time of mass medical confusion and cultural homophobia associated with HIV/AIDS. The current FDA ban is wildly outdated and perpetuates unfair labels against gay and bisexual men that live on through decades of discrimination."

POZ Opinion: Reevaluate the FDA Gay Blood Ban

A gay California mayor wants to stop discrimination against gay men who want to donate blood:

"The ban was imposed in 1983 when there were no reliable tests for screening blood for HIV/AIDS. It was also made during a time of mass medical confusion and cultural homophobia associated with HIV/AIDS. The current FDA ban is wildly outdated and perpetuates unfair labels against gay and bisexual men that live on through decades of discrimination."

lgbtqblogs

gaywrites:

This is absolutely brilliant. 

For almost 30 years, the FDA has banned men who have sex with men (MSM) from donating blood because of this demographic’s historically high rate of HIV. Screening practices have become far more advanced since that time and ALL donated blood is tested for HIV before being passed on to a patient, and yet the ban remains, presumably because of outdated, discriminatory stereotypes about gay men and HIV/AIDS. 

On July 12, MSM around the country have a chance to prove the FDA wrong — by collectively showing up at blood banks and, when they are denied the chance to donate, proving the FDA’s policy worthless. Here are the details:

All across the country on July 12 from 9am to 5pm PST, gay and bisexual men, (also known as “MSM donors”) can show up to a designated blood donation center where a mobile HIV testing center will be waiting. The men will be tested, and once the test is negative, they can attempt to donate blood. When the men are rejected from giving blood, their HIV test results will be compiled and delivered to the FDA, to show the administration why they should lift their ban.

Words can’t explain how pumped I am for this. If enough people participate, the results wil send a powerful message about the absurdity of this policy. Please, please spread the word and stay tuned for more information. 

FDA Approves First Drug to Treat Diarrhea in People With HIV
The U.S. Food and Drug Administration (FDA) has approved Fulyzaq (crofelemer), the first drug to relieve symptoms of diarrhea that is a side effect of HIV antiretrovirals (ARVs). Intended for use among people with HIV who are taking ARVs and whose diarrhea is not caused by a virus, bacteria or parasite, the drug treats watery diarrhea that is a consequence of electrolyte secretion and water in the gastrointestinal tract.
Read more… http://www.poz.com/articles/fulyzaq_crofelemer_salix_761_23339.shtml

FDA Approves First Drug to Treat Diarrhea in People With HIV

The U.S. Food and Drug Administration (FDA) has approved Fulyzaq (crofelemer), the first drug to relieve symptoms of diarrhea that is a side effect of HIV antiretrovirals (ARVs). Intended for use among people with HIV who are taking ARVs and whose diarrhea is not caused by a virus, bacteria or parasite, the drug treats watery diarrhea that is a consequence of electrolyte secretion and water in the gastrointestinal tract.

Read more… http://www.poz.com/articles/fulyzaq_crofelemer_salix_761_23339.shtml